Erfahren Sie mehr:
Publikationen
- Venous Admixture in COPD: Journal of COPD
- Percutaneous Creation of Arteriovenous Shunts: Vascular Disease Management
- An Arteriovenoius Fistula Increase Exercise Capacity in Patients with COPD: CHEST
ROX Medical Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients
SAN CLEMENTE, Calif | 31. Oktober 2011
SAN CLEMENTE, Calif | 31. Oktober 2011
ROX Medical, Inc. today announced the first clinical use of the ROX CO2UPLERTM at the Universitair Ziekenhuis Brussel (University Hospital of Brussels) to treat resistant hypertension. "We are pleased to have performed the first ever ROX FLO2W Procedure for this new approach to hypertension, the acute impact on the patients blood pressure was greater than we expected and we look forward to understanding how much these patients benefit from the treatment over time."
ROX Medical Initiiert Ein Phase IV Register In Deutschland Für Das Minimal Invasive CO2UPLER Implantatverfahren Für Patienten Mit Chronisch Obstruktiver Lungenkrankrankheit Begleitend Zur Produkteinführung
SAN CLEMENTE, Calif | 01. Dezember 2010
ROX Medical, INC., Hersteller eines einzigartigen minimal invasiven Implantats fur die Behandlung von fortgeschrittener COPD, gab heute die Initiierung eines deutschen Phase IV Registers bekannt.